Ari D Schuman1, John D Syrjamaki2, Edward C Norton3, Brian R Hallstrom4, Scott E Regenbogen5. 1. Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, MI; Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, TX. 2. Michigan Value Collaborative, Ann Arbor, MI; Department of Surgery, University of Michigan Medical School, Ann Arbor, MI. 3. Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, MI; Michigan Value Collaborative, Ann Arbor, MI. 4. Department of Orthopedic Surgery, University of Michigan Medical School, Ann Arbor, MI. 5. Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor, MI; Michigan Value Collaborative, Ann Arbor, MI; Department of Surgery, University of Michigan Medical School, Ann Arbor, MI. Electronic address: sregenbo@med.umich.edu.
Abstract
BACKGROUND: Extended care facility use is a primary driver of variation in hospitalization-associated health care payments and is increasingly a focus for savings under episode-based payment. However, concerns remain that extended care facility limits could incur rising readmissions, emergency department use, or other costs. We analyzed the effects of a statewide value improvement initiative to decrease extended care facility use after lower extremity arthroplasty on extended care facility use, readmission, emergency department use, and payments. METHODS: We performed a retrospective cohort study using complete claims from the Michigan Value Collaborative for patients undergoing lower extremity joint replacement. We compared the change in extended care facility use before (2012-2013) and after (2016-2017) the aforementioned statewide initiative with 90-day postacute care, readmission, and emergency department rates and payments using t tests. RESULTS: Of the patients included, 68,537 underwent total knee arthroplasty; 27,131 underwent total hip arthroplasty. Statewide, extended care facility use and postacute care payments decreased (extended care facility: 27.5% before vs 18.1% after, payments: $4,999 vs $3,832, P < .0001) without increased readmission rates (8.0% vs 7.6%, P = .10) or payments ($1,087 vs $1,026, P = .14). Emergency department use increased (7.8% vs 8.9%, P < .0001). Per hospital, there was no association between extended care facility use change and readmission rate change (r = 0.05). Hospital change in extended care facility use ranged from +2.3% (no extended care facility decrease group) to -16.6% (large extended care facility decrease group) and was associated with lower total episode payments without differences in change in readmission rate/payments or emergency department use. CONCLUSION: Despite decreased use of extended care facilities, there was no compensatory increase in readmission rate or payments. Reducing excess use of extended care facilities after joint replacement may be an important opportunity for savings in episode-based reimbursement.
BACKGROUND: Extended care facility use is a primary driver of variation in hospitalization-associated health care payments and is increasingly a focus for savings under episode-based payment. However, concerns remain that extended care facility limits could incur rising readmissions, emergency department use, or other costs. We analyzed the effects of a statewide value improvement initiative to decrease extended care facility use after lower extremity arthroplasty on extended care facility use, readmission, emergency department use, and payments. METHODS: We performed a retrospective cohort study using complete claims from the Michigan Value Collaborative for patients undergoing lower extremity joint replacement. We compared the change in extended care facility use before (2012-2013) and after (2016-2017) the aforementioned statewide initiative with 90-day postacute care, readmission, and emergency department rates and payments using t tests. RESULTS: Of the patients included, 68,537 underwent total knee arthroplasty; 27,131 underwent total hip arthroplasty. Statewide, extended care facility use and postacute care payments decreased (extended care facility: 27.5% before vs 18.1% after, payments: $4,999 vs $3,832, P < .0001) without increased readmission rates (8.0% vs 7.6%, P = .10) or payments ($1,087 vs $1,026, P = .14). Emergency department use increased (7.8% vs 8.9%, P < .0001). Per hospital, there was no association between extended care facility use change and readmission rate change (r = 0.05). Hospital change in extended care facility use ranged from +2.3% (no extended care facility decrease group) to -16.6% (large extended care facility decrease group) and was associated with lower total episode payments without differences in change in readmission rate/payments or emergency department use. CONCLUSION: Despite decreased use of extended care facilities, there was no compensatory increase in readmission rate or payments. Reducing excess use of extended care facilities after joint replacement may be an important opportunity for savings in episode-based reimbursement.
Authors: Lindsay E Jubelt; Keith S Goldfeld; Wei-yi Chung; Saul B Blecker; Leora I Horwitz Journal: JAMA Intern Med Date: 2016-01 Impact factor: 21.873
Authors: Chad Ellimoottil; John D Syrjamaki; Benedict Voit; Vinay Guduguntla; David C Miller; James M Dupree Journal: Am J Manag Care Date: 2017-11-01 Impact factor: 2.229
Authors: Andrew D Wilcock; Michael L Barnett; J Michael McWilliams; David C Grabowski; Ateev Mehrotra Journal: JAMA Surg Date: 2020-01-01 Impact factor: 14.766
Authors: Daniel J Gottlieb; Weiping Zhou; Yunjie Song; Kathryn Gilman Andrews; Jonathan S Skinner; Jason M Sutherland Journal: Health Aff (Millwood) Date: 2010-01-28 Impact factor: 6.301
Authors: Karthikeyan E Ponnusamy; Zan Naseer; Mostafa H El Dafrawy; Louis Okafor; Clayton Alexander; Robert S Sterling; Harpal S Khanuja; Richard L Skolasky Journal: J Bone Joint Surg Am Date: 2017-06-07 Impact factor: 5.284
Authors: Ryan J Charles; Bonita M Singal; Andrew G Urquhart; Michael A Masini; Brian R Hallstrom Journal: J Arthroplasty Date: 2016-11-28 Impact factor: 4.757
Authors: Trudy R Mallinson; Jillian Bateman; Hsiang-Yi Tseng; Larry Manheim; Orit Almagor; Anne Deutsch; Allen W Heinemann Journal: Arch Phys Med Rehabil Date: 2011-05 Impact factor: 3.966
Authors: Amol S Navathe; Andrea B Troxel; Joshua M Liao; Nan Nan; Jingsan Zhu; Wenjun Zhong; Ezekiel J Emanuel Journal: JAMA Intern Med Date: 2017-02-01 Impact factor: 21.873
Authors: Nizar N Mahomed; Aileen M Davis; Gillian Hawker; Elizabeth Badley; J Rod Davey; Khalid A Syed; Peter C Coyte; Rajiv Gandhi; James G Wright Journal: J Bone Joint Surg Am Date: 2008-08 Impact factor: 5.284
Authors: Stefano A Bini; Donald C Fithian; Liz W Paxton; Monti X Khatod; Maria C Inacio; Robert S Namba Journal: J Arthroplasty Date: 2009-01-15 Impact factor: 4.757